Know Cancer

or
forgot password

The Effect of Genetic Polymorphisms in Indoleamine 2, 3-Dioxygenase in Epithelial Ovarian Cancer


N/A
20 Years
90 Years
Not Enrolling
Female
Ovarian Cancer

Thank you

Trial Information

The Effect of Genetic Polymorphisms in Indoleamine 2, 3-Dioxygenase in Epithelial Ovarian Cancer


Inclusion Criteria:



- females aged 20-90 who are having surgery to confirm epithelial ovarian cancer.

Exclusion Criteria:

- patients who have a diagnosis of non-epithelial histology.

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

To examine the association of indoleamine 2,3-dioxygenase (IDO) genetic polymorphisms with clinical outcomes of ovarian cancer.

Outcome Time Frame:

one year

Safety Issue:

No

Principal Investigator

Jeannine A Villella, D.O.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Winthrop University Hospital

Authority:

United States: Federal Government

Study ID:

09316

NCT ID:

NCT01042847

Start Date:

January 2010

Completion Date:

January 2011

Related Keywords:

  • Ovarian Cancer
  • ovarian
  • Ovarian Neoplasms

Name

Location
Winthrop-University Hospital Mineola, New York  11501